000157103 001__ 157103
000157103 005__ 20240229123129.0
000157103 0247_ $$2doi$$a10.1093/hmg/ddaa147
000157103 0247_ $$2pmid$$apmid:32657331
000157103 0247_ $$2ISSN$$a0964-6906
000157103 0247_ $$2ISSN$$a1460-2083
000157103 0247_ $$2altmetric$$aaltmetric:85758512
000157103 037__ $$aDKFZ-2020-01394
000157103 041__ $$aeng
000157103 082__ $$a570
000157103 1001_ $$0P:(DE-He78)45440b44791309bd4b7dbb4f73333f9b$$aSill, Martin$$b0$$eFirst author$$udkfz
000157103 245__ $$aMolecular tumor classification using DNA methylome analysis.
000157103 260__ $$aOxford$$bOxford Univ. Press$$c2020
000157103 3367_ $$2DRIVER$$aarticle
000157103 3367_ $$2DataCite$$aOutput Types/Journal article
000157103 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1630414820_30128$$xReview Article
000157103 3367_ $$2BibTeX$$aARTICLE
000157103 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000157103 3367_ $$00$$2EndNote$$aJournal Article
000157103 500__ $$a2020 Oct 20;29(R2):R205-R213#EA:B062#LA:B340#
000157103 520__ $$aTumor classifiers based on molecular patterns promise to define and reliably classify tumor entities. The high tissue- and cell type-specificity of DNA methylation, as well as its high stability, makes DNA methylation an ideal choice for the development of tumor classifiers. Herein, we review existing tumor classifiers using DNA methylome analysis and will provide an overview on their emerging impact on cancer classification, the detection of novel cancer subentities and patient stratification with a focus on brain tumors, sarcomas and hematopoietic malignancies. Furthermore, we provide an outlook on the enormous potential of DNA methylome analysis to complement classical histopathological and genetic diagnostics, including the emerging field of epigenomic analysis in liquid biopsies.
000157103 536__ $$0G:(DE-HGF)POF3-312$$a312 - Functional and structural genomics (POF3-312)$$cPOF3-312$$fPOF III$$x0
000157103 588__ $$aDataset connected to CrossRef, PubMed,
000157103 7001_ $$0P:(DE-He78)4301875630bc997edf491c694ae1f8a9$$aPlass, Christoph$$b1$$udkfz
000157103 7001_ $$0P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9$$aPfister, Stefan M$$b2$$udkfz
000157103 7001_ $$0P:(DE-He78)c403a040c97f91902a7d31b93859f9fc$$aLipka, Daniel$$b3$$eLast author$$udkfz
000157103 773__ $$0PERI:(DE-600)1474816-2$$a10.1093/hmg/ddaa147$$gp. ddaa147$$nR2$$pR205-R213$$tHuman molecular genetics$$v29$$x1460-2083$$y2020
000157103 909CO $$ooai:inrepo02.dkfz.de:157103$$pVDB
000157103 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)45440b44791309bd4b7dbb4f73333f9b$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000157103 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4301875630bc997edf491c694ae1f8a9$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000157103 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000157103 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c403a040c97f91902a7d31b93859f9fc$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000157103 9131_ $$0G:(DE-HGF)POF3-312$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunctional and structural genomics$$x0
000157103 9141_ $$y2020
000157103 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2020-01-11$$wger
000157103 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-01-11
000157103 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-01-11
000157103 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database$$d2020-01-11
000157103 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2020-01-11
000157103 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-01-11
000157103 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index$$d2020-01-11
000157103 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-01-11
000157103 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-01-11
000157103 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-01-11
000157103 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2020-01-11
000157103 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2020-01-11
000157103 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2020-01-11
000157103 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bHUM MOL GENET : 2018$$d2020-01-11
000157103 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2020-01-11
000157103 9202_ $$0I:(DE-He78)B340-20160331$$kB340$$lTranslationale Medizinische Onkologie$$x0
000157103 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x0
000157103 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x1
000157103 9201_ $$0I:(DE-He78)B370-20160331$$kB370$$lEpigenomik$$x2
000157103 9201_ $$0I:(DE-He78)B340-20160331$$kB340$$lTranslationale Medizinische Onkologie$$x3
000157103 9200_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x0
000157103 980__ $$ajournal
000157103 980__ $$aVDB
000157103 980__ $$aI:(DE-He78)B062-20160331
000157103 980__ $$aI:(DE-He78)HD01-20160331
000157103 980__ $$aI:(DE-He78)B370-20160331
000157103 980__ $$aI:(DE-He78)B340-20160331
000157103 980__ $$aUNRESTRICTED